Continuous hemoadsorption with a cytokine adsorber during sepsis – A review of the literature

International Journal of Artificial Organs

Volumn 40, Issue 5, 2017, Pages 205-211

  Houschyar, Khosrow S ^a   Pyles, Malcolm N ^b   Rein, Susanne ^a   Nietzschmann, Ina ^a   Duscher, Dominik ^c,d   Maan, Zeshaan N ^b   Weissenberg, Kristian ^a   Philipps, Hubertus M ^a   Strauss, Catharina ^e   Reichelt, Beate ^a   Siemers, Frank ^a  

^a BG KLINIKEN BERGMANNSTROST   (Germany)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHANNES KEPLER UNIVERSITY LINZ   (Austria)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e CARITAS KRANKENHAUS ST JOSEF   (Germany)

Author keywords

Cytokines; CytoSorb ; Hemoadsorption; Inflammation; Sepsis

Indexed keywords

ADSORPTION; NITRIC OXIDE; PATIENT TREATMENT;

ADSORBERS; CYTOKINES; CYTOSORB®; HEMOADSORPTION; IL-1Β; INFLAMMATORY CYTOKINES; INFLAMMATORY RESPONSE; RESOURCES UTILIZATIONS; SEPSIS; TNF Α;

DISEASES;

C REACTIVE PROTEIN; CD163 ANTIGEN; CD64 ANTIGEN; CHEMOKINE RECEPTOR CX3CR1; COMPLEMENT FACTOR; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LACTIC ACID; PATHOGEN ASSOCIATED MOLECULAR PATTERN; PLASMINOGEN; PROCALCITONIN; TUMOR NECROSIS FACTOR; CYTOKINE;

ADULT RESPIRATORY DISTRESS SYNDROME; APOPTOSIS; AUTOPSY; BLOOD FILTER; BLOOD VESSEL OCCLUSION; CARDIOPULMONARY BYPASS; CATABOLISM; CRITICAL ILLNESS; CYTOKINE STORM; HEMADSORPTION; HUMAN; HYPOTENSION; INFLAMMATION; MENTAL FUNCTION; META ANALYSIS (TOPIC); MULTIPLE ORGAN FAILURE; NECROTIZING FASCIITIS; NONHUMAN; PATHOPHYSIOLOGY; RENAL REPLACEMENT THERAPY; REVIEW; SEPSIS; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; SYSTEMIC VASCULAR RESISTANCE; ANIMAL; BLOOD; HEMOPERFUSION; PROCEDURES;

ANIMALS; CYTOKINES; HEMADSORPTION; HEMOPERFUSION; HUMANS; MULTIPLE ORGAN FAILURE; SEPSIS;

EID: 85020183124     PISSN: 03913988     EISSN: 17246040     Source Type: Journal    
DOI: 10.5301/ijao.5000591     Document Type: Review

References (53)

1. Crowther MA, Marshall JC. Continuing challenges of sepsis research. JAMA. 2001; 286 (15): 1894-1896.
2. Iskander KN, Osuchowski MF, Stearns-Kurosawa DJ, et al. Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding. Physiol Rev. 2013; 93 (3): 1247-1288.
3. Lee PA, Matson JR, Pryor RW, Hinshaw LB. Continuous arteriovenous hemofiltration therapy for Staphylococcus aureusinduced septicemia in immature swine. Crit Care Med. 1993; 21 (6): 914-924.
4. Grootendorst AF, van Bommel EF, van Leengoed LA, van Zanten AR, Huipen HJ, Groeneveld AB. Infusion of ultrafiltrate from endotoxemic pigs depresses myocardial performance in normal pigs. J Crit Care. 1993; 8 (3): 161-169.
5. Bellomo R, Tipping P, Boyce N. Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med. 1993; 21 (4): 522-526.
6. Bellomo R, Parkin G, Love J, Boyce N. A prospective comparative study of continuous arteriovenous hemodiafiltration and continuous venovenous hemodiafiltration in critically ill patients. Am J Kidney Dis. 1993; 21 (4): 400-404.
7. Shum HP, Yan WW, Chan TM. Extracorporeal blood purification for sepsis. Hong Kong Med J. 2016; 22 (5): 478-485.
8. Taniguchi T. Cytokine adsorbing columns. Contrib Nephrol. 2010; 166: 134-141.
9. Venkataraman R, Subramanian S, Kellum JA. Clinical review: extracorporeal blood purification in severe sepsis. Crit Care. 2003; 7 (2): 139-145.
10. Wiegele M, Krenn CG. Cytosorb™ in a patient with Legionella pneumonia-associated rhabdomyolysis: a case report. ASAIO J. 2015; 61 (3): e14-e16.
11. Kuntsevich VI, Feinfeld DA, Audia PF, et al. In-vitro myoglobin clearance by a novel sorbent system. Artif Cells Blood Substit Immobil Biotechnol. 2009; 37 (1): 45-47.
12. Linden K, Scaravilli V, Kreyer SF, et al. Evaluation of the Cytosorb ™ Hemoadsorptive Column in a Pig Model of Severe Smoke and Burn Injury. Shock. 2015; 44 (5): 487-495.
13. Pierce G, Murray PR. Current controversies in the detection of septicemia. Eur J Clin Microbiol. 1986; 5 (5): 487-491.
14. Balk RA. Systemic inflammatory response syndrome (SIRS): where did it come from and is it still relevant today? Virulence. 2014; 5 (1): 20-26.
15. Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315 (8): 801-810.
16. Siegler BH, Brenner T, Uhle F, Weiterer S, Weigand MA, Hofer S. Why a second look might be worth it: immuno-modulatory therapies in the critically ill patient. J Thorac Dis. 2016; 8 (6): E424-E430.
17. Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013; 369 (21): 2063.
18. Wiersinga WJ, Leopold SJ, Cranendonk DR, van der Poll T. Host innate immune responses to sepsis. Virulence. 2014; 5 (1): 36-44.
19. Laszlo I, Trasy D, Molnar Z, Fazakas J. Sepsis: From Pathophysiology to Individualized Patient Care. J Immunol R. 2015; 2015: 510436.
20. Kozlov AV, Bahrami S, Calzia E, et al. Mitochondrial dysfunction and biogenesis: do ICU patients die from mitochondrial failure? Ann Intensive Care. 2011; 1 (1): 41.
21. Zhang Q, Raoof M, Chen Y, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature. 2010; 464 (7285): 104-107.
22. Frevert CW, Martin TR. Sepsis and the lung host response. Semin Respir Crit Care Med. 2004; 25 (1): 85-93.
23. Stearns-Kurosawa DJ, Osuchowski MF, Valentine C, Kurosawa S, Remick DG. The pathogenesis of sepsis. Annu Rev Pathol. 2011; 6: 19-48.
24. Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med. 2008; 36 (3): 941-952.
25. Remick DG. Cytokine therapeutics for the treatment of sepsis: why has nothing worked? Curr Pharm Des. 2003; 9 (1): 75-82.
26. Pachot A, Cazalis MA, Venet F, et al. Decreased expression of the fractalkine receptor CX3CR1 on circulating monocytes as new feature of sepsis-induced immunosuppression. J Immunol. 2008; 180 (9): 6421-6429.
27. Hotchkiss RS, Swanson PE, Cobb JP, Jacobson A, Buchman TG, Karl IE. Apoptosis in lymphoid and parenchymal cells during sepsis: findings in normal and T-and B-cell-deficient mice. Crit Care Med. 1997; 25 (8): 1298-1307.
28. Hotchkiss RS, Swanson PE, Freeman BD, et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med. 1999; 27 (7): 1230-1251.
29. Peschanski N, Chenevier-Gobeaux C, Mzabi L, et al. Prognostic value of PCT in septic emergency patients. Ann Intensive Care. 2016; 6 (1): 47.
30. Liu D, Su L, Han G, Yan P, Xie L. Prognostic Value of Procalcitonin in Adult Patients with Sepsis: A Systematic Review and Meta-Analysis. PLoS One. 2015; 10 (6): e0129450.
31. Ren H, Li Y, Han C, Hu H. Serum procalcitonin as a diagnostic biomarker for sepsis in burned patients: a meta-analysis. Burns. 2015; 41 (3): 502-509.
32. Remick DG. Pathophysiology of sepsis. Am J Pathol. 2007; 170 (5): 1435-1444.
33. Oberholzer A, Souza SM, Tschoeke SK, et al. Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis. Shock. 2005; 23 (6): 488-493.
34. Standage SW, Wong HR. Biomarkers for pediatric sepsis and septic shock. Expert Rev Anti Infect Ther. 2011; 9 (1): 71-79.
35. Faix JD. Biomarkers of sepsis. Crit Rev Clin Lab Sci. 2013; 50 (1): 23-36.
36. Reinhart K, Bauer M, Riedemann NC, Hartog CS. New approaches to sepsis: molecular diagnostics and biomarkers. Clin Microbiol Rev. 2012; 25 (4): 609-634.
37. Taylor RA, Pare JR, Venkatesh AK, et al. Prediction of In-hospital Mortality in Emergency Department Patients With Sepsis: A Local Big Data-Driven, Machine Learning Approach. Acad Emerg Med. 2016; 23 (3): 269-278.
38. Park S, Cho GY, Kim SG, et al. Brain natriuretic peptide levels have diagnostic and prognostic capability for cardio-renal syndrome type 4 in intensive care unit patients. Crit Care. 2009; 13 (3): R70.
39. Baumann A, Buchwald D, Annecke T, Hellmich M, Zahn PK, Hohn A. RECCAS-REmoval of Cytokines during CArdiac Surgery: study protocol for a randomised controlled trial. Trials. 2016; 17 (1): 137.
40. Harm S, Gabor F, Hartmann J. Characterization of Adsorbents for Cytokine Removal from Blood in an In Vitro Model. J Immunol R. 2015; 2015: 484736.
41. Cerdá J, Baldwin I, Honore PM, Villa G, Kellum JA, Ronco C. ADQI Consensus Group. Role of Technology for the Management of AKI in Critically Ill Patients: From Adoptive Technology to Precision Continuous Renal Replacement Therapy. Blood Purif. 2016; 42 (3): 248-265.
42. Peng ZY, Carter MJ, Kellum JA. Effects of hemoadsorption on cytokine removal and short-term survival in septic rats. Crit Care Med. 2008; 36 (5): 1573-1577.
43. Kellum JA, Song M, Venkataraman R. Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-kappaB DNA binding, and improves short-term survival in lethal endotoxemia. Crit Care Med. 2004; 32 (3): 801-805.
44. Hetz H, Berger R, Recknagel P, Steltzer H. Septic shock secondary to β-hemolytic streptococcus-induced necrotizing fasciitis treated with a novel cytokine adsorption therapy. Int J Artif Organs. 2014; 37 (5): 422-426.
45. Finnerty CC, Przkora R, Herndon DN, Jeschke MG. Cytokine expression profile over time in burned mice. Cytokine. 2009; 45 (1): 20-25.
46. Kataranovski M, Magić Z, Pejnović N. Early inflammatory cytokine and acute phase protein response under the stress of thermal injury in rats. Physiol Res. 1999; 48 (6): 473-482.
47. Amado JA, López-Espadas F, Vázquez-Barquero A, et al. Blood levels of cytokines in brain-dead patients: relationship with circulating hormones and acute-phase reactants. Metabolism. 1995; 44 (6): 812-816.
48. Peng ZY, Bishop JV, Wen XY, et al. Modulation of chemokine gradients by apheresis redirects leukocyte trafficking to different compartments during sepsis, studies in a rat model. Crit Care. 2014; 18 (4): R141.
49. Bruenger F, Kizner L, Weile J, Morshuis M, Gummert JF. First successful combination of ECMO with cytokine removal therapy in cardiogenic septic shock: a case report. Int J Artif Organs. 2015; 38 (2): 113-116.
50. Tomescu DR, Olimpia Dima S, Ungureanu D, Popescu M, Tulbure D, Popescu I. First report of cytokine removal using CytoSorb® in severe noninfectious inflammatory syndrome after liver transplantation. Int J Artif Organs. 2016; 39 (3): 136-140.
51. Hinz B, Jauch O, Noky T, Friesecke S, Abel P, Kaiser R. CytoSorb, a novel therapeutic approach for patients with septic shock: a case report. Int J Artif Organs. 2015; 38 (8): 461-464.
52. Träger K, Fritzler D, Fischer G, et al. Treatment of post-cardiopulmonary bypass SIRS by hemoadsorption: a case series. Int J Artif Organs. 2016; 39 (3): 141-146.
53. Houschyar KS, Nietzschmann I, Siemers F. [The Use of a Cytokine Adsorber (CytoSorb) in a Patient with Septic Shock and Multi-Organ Dysfunction (MODS) after a Severe Burn Injury]. [Article in German] Handchir Mikrochir Plast Chir. 2016 Dec 8. [Epub ahead of print].